# A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With COPD

> **NCT02233686** · PHASE2 · COMPLETED · sponsor: **Xention Ltd** · enrollment: 27 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** XEN-D0501
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02233686
- **Lead sponsor:** Xention Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2015-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02233686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02233686, "A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With COPD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02233686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*